Benzinga
Benzinga
Benzinga
domenica, settembre 20

Crescent Biopharma Inc

CBIONASDAQ
Trade with Public
Trade with Public
$16.89
0.120.72%
In chiusura: Sep 18, 5:00 PM EST
$16.84
-0.05-0.3%
Post-mercato: Sep 18, 4:22 PM EST
PanoramicaNotiziePrevisioni utiliEventiObiettivi di prezzoDati finanziariSentimentAzionariatoConfrontaOpzioniRapporto azionario

Crescent Biopharma Analyst Price Targets

Wall Street analyst price targets and consensus rating for Crescent Biopharma (CBIO).

Price Target Range — 4 Quarters

Analyst Consensus — 6 Analysts

5Buy
1Hold
Consensus RatingBuy# Analysts6Avg. Consensus PT$28Upside to Avg. PT+63.9%

Rating Trend — Last 9 Months

Recent Analyst Actions

Visualizza tutte le valutazioni →
DateFirmAnalystActionRating ChangePrice Target
Sep 14, 2026WedbushRobert DriscollMaintainedOutperform$27
Aug 27, 2026WedbushRobert DriscollMaintainedOutperform$27
More with Benzinga EdgeGet Access

Analyst Ratings News

PRO
Wedbush Reiterates Outperform on Crescent Biopharma, Maintains $27 Price Target

Wedbush analyst Robert Driscoll reiterates Crescent Biopharma (NASDAQ:CBIO) with a Outperform and maintains $27 price target.
Benzinga Newsdesk

PRO
Wedbush Reiterates Outperform on Crescent Biopharma, Maintains $27 Price Target

Wedbush analyst Robert Driscoll reiterates Crescent Biopharma (NASDAQ:CBIO) with a Outperform and maintains $27 price target.
Benzinga Newsdesk

This Craig-Hallum Analyst Turns Bearish; Here Are Top 5 Downgrades For Monday

Analysts downgraded ratings on Cardiff Oncology, Crescent Biopharma, Corsair Gaming, Equity Residential and Caesars Entertainment.
Avi Kapoor

PRO
HC Wainwright & Co. Downgrades Crescent Biopharma to Neutral

HC Wainwright & Co. analyst Mitchell S. Kapoor downgrades Crescent Biopharma (NASDAQ:CBIO) from Buy to Neutral.
Benzinga Newsdesk

PRO
HC Wainwright & Co. Maintains Buy on Crescent Biopharma, Lowers Price Target to $22

HC Wainwright & Co. analyst Mitchell S. Kapoor maintains Crescent Biopharma (NASDAQ:CBIO) with a Buy and lowers the price target from $25 to $22.
Benzinga Newsdesk

This Crescent Biopharma Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday

Avi Kapoor

Dati e API: API Benzinga · API notizie azionarie · API valutazioni analisti · API logo aziende

Dati di mercato forniti da API Benzinga

Benzinga

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO

© 2026 Benzinga | All Rights Reserved